These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8428340)

  • 21. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
    Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
    Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth factors and oncogenes in prostate cancer.
    Thompson TC
    Cancer Cells; 1990 Nov; 2(11):345-54. PubMed ID: 2282250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Bang YJ; Kim SJ; Danielpour D; O'Reilly MA; Kim KY; Myers CE; Trepel JB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3556-60. PubMed ID: 1373503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.
    Story MT; Hopp KA; Molter M
    J Cell Physiol; 1996 Oct; 169(1):97-107. PubMed ID: 8841426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer in a transgenic mouse.
    Greenberg NM; DeMayo F; Finegold MJ; Medina D; Tilley WD; Aspinall JO; Cunha GR; Donjacour AA; Matusik RJ; Rosen JM
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3439-43. PubMed ID: 7724580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes.
    Yang G; Timme TL; Park SH; Thompson TC
    Prostate; 1997 Nov; 33(3):151-6. PubMed ID: 9365541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
    Cui W; Fowlis DJ; Cousins FM; Duffie E; Bryson S; Balmain A; Akhurst RJ
    Genes Dev; 1995 Apr; 9(8):945-55. PubMed ID: 7774812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of transforming growth factor-beta 1 in prostate cancer.
    Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
    Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).
    Mentor-Marcel R; Lamartiniere CA; Eltoum IA; Greenberg NM; Elgavish A
    J Nutr; 2005 May; 135(5):989-95. PubMed ID: 15867270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexim-1 modulates androgen receptor and the TGF-β signaling during the progression of prostate cancer.
    Mascareno EJ; Belashov I; Siddiqui MA; Liu F; Dhar-Mascareno M
    Prostate; 2012 Jun; 72(9):1035-44. PubMed ID: 22095517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
    Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
    BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.